Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Sumitomo Chemical India Limited
  6. Financials
    542920   INE258G01013

SUMITOMO CHEMICAL INDIA LIMITED

(542920)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2020 2021 2022 2023 2024
Capitalization1 91 568145 152220 498--
Enterprise Value (EV)1 90 415140 041214 166210 696205 693
P/E ratio 44,7x42,0x50,0x45,4x38,6x
Yield 0,30%0,28%0,20%0,23%0,27%
Capitalization / Revenue 3,78x5,49x7,29x6,46x5,68x
EV / Revenue 3,73x5,29x7,08x6,18x5,30x
EV / EBITDA 27,1x28,8x37,3x31,7x26,5x
Price to Book 7,49x9,42x10,9x8,85x7,73x
Nbr of stocks (in thousands) 499 146499 146499 146--
Reference price (INR) 183291442442442
Announcement Date 06/05/202005/28/2021---
1 INR in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: March 2020 2021 2022 2023 2024
Net sales1 24 24726 44930 23934 11038 811
EBITDA1 3 3324 8695 7356 6547 767
Operating profit (EBIT)1 2 9224 4035 3636 2487 567
Operating Margin 12,1%16,6%17,7%18,3%19,5%
Pre-Tax Profit (EBT)1 2 6654 5335 5326 4597 590
Net income1 2 0473 4544 1294 8475 720
Net margin 8,44%13,1%13,7%14,2%14,7%
EPS2 4,106,928,849,7311,5
Dividend per Share2 0,550,800,881,001,20
Announcement Date 06/05/202005/28/2021---
1 INR in Million
2 INR
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: March 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3
Net sales1 9 0205 6095 3437 82010 1006 312
EBITDA1 2 1897807131 4982 300852
Operating profit (EBIT) ------
Operating Margin ------
Pre-Tax Profit (EBT)1 -709-1 423--
Net income1 -5415411 057--
Net margin -9,65%10,1%13,5%--
EPS ------
Dividend per Share ------
Announcement Date 11/05/202002/05/202105/28/202108/04/2021--
1 INR in Million
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: March 2020 2021 2022 2023 2024
Net Debt1 -----
Net Cash position1 1 1535 1106 3329 80214 805
Leverage (Debt / EBITDA) -0,35x-1,05x-1,10x-1,47x-1,91x
Free Cash Flow1 1 8343 8222 0512 9913 543
ROE (Net Profit / Equities) 18,0%25,0%23,7%22,8%21,9%
Shareholders' equity1 11 35113 81517 45221 29726 093
ROA (Net Profit / Asset) 10,3%14,5%13,7%13,6%12,9%
Assets1 19 83123 88130 14135 64244 337
Book Value Per Share2 24,530,940,649,957,1
Cash Flow per Share -8,52---
Capex1 3804331 2571 4001 490
Capex / Sales 1,57%1,64%4,16%4,10%3,84%
Announcement Date 06/05/202005/28/2021---
1 INR in Million
2 INR
Estimates
Key data
Capitalization (INR) 220 497 628 878
Capitalization (USD) 2 833 766 378
Net sales (INR) 26 449 060 000
Net sales (USD) 339 915 025
Number of employees 1 722
Sales / Employee (INR) 15 359 501
Sales / Employee (USD) 197 395
Free-Float 24,6%
Free-Float capitalization (INR) 54 252 272 583
Free-Float capitalization (USD) 697 233 194
Avg. Exchange 20 sessions (INR) 24 153 123
Avg. Exchange 20 sessions (USD) 310 408
Average Daily Capital Traded 0,01%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA